These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Use of anticholinergics to treat bradycardia caused by alpha1-adrenergic agonist overdose is not safe. Sprung J; Alhaddad ST J Clin Anesth; 1996 Aug; 8(5):426-7. PubMed ID: 8832455 [No Abstract] [Full Text] [Related]
3. Bradycardia, hypotension, and near-syncope associated with Afrin (oxymetazoline) nasal spray. Glazener F; Blake K; Gradman M N Engl J Med; 1983 Sep; 309(12):731. PubMed ID: 6888446 [No Abstract] [Full Text] [Related]
5. Non-ST-elevation myocardial infarction with the use of oxymetazoline nasal spray. Rajpal S; Morris LA; Akkus NI Rev Port Cardiol; 2014 Jan; 33(1):51.e1-4. PubMed ID: 24405558 [TBL] [Abstract][Full Text] [Related]
6. ["Of snakes and crocodiles": central side effects of nose drops and facts about rhinitis medicamentosa]. Bielenberg J Kinderkrankenschwester; 2011 Oct; 30(10):406-8. PubMed ID: 22029138 [No Abstract] [Full Text] [Related]
7. Case report: 2 cases of cardiac arrest caused by rhino-cardiac reflex while disinfecting nasal cavity before endonasal transsphenoidal endoscopic pituitary surgery. Wang W; Cai H; Ding H; Xu X BMC Anesthesiol; 2021 Jan; 21(1):18. PubMed ID: 33441081 [TBL] [Abstract][Full Text] [Related]
8. Use of sympathomimetic nasal spray in association with cardiac fibroma: an unusual cause of ventricular tachycardia. Khan A; Dewhurst N Br J Clin Pract; 1997; 51(3):192-3. PubMed ID: 9293069 [TBL] [Abstract][Full Text] [Related]
9. Four-week use of oxymetazoline nasal spray (Nezeril) once daily at night induces rebound swelling and nasal hyperreactivity. Graf P; Hallén H; Juto JE Acta Otolaryngol; 1995 Jan; 115(1):71-5. PubMed ID: 7762389 [TBL] [Abstract][Full Text] [Related]
11. Sudden cardiac standstill during skin flap elevation in a patient undergoing craniotomy. Prabhakar H; Rath GP; Arora R J Neurosurg Anesthesiol; 2007 Jul; 19(3):203-4. PubMed ID: 17592354 [No Abstract] [Full Text] [Related]
12. Oxymetazoline and hypertensive crisis in a child: can we prevent it? Latham GJ; Jardine DS Paediatr Anaesth; 2013 Oct; 23(10):952-6. PubMed ID: 23679077 [TBL] [Abstract][Full Text] [Related]
13. Sinus arrest with prolonged asystole due to the trigeminocardiac reflex during application of local anaesthetic in the nasal mucosa. Meuwly C; Leibundgut G; Rosemann T; Schaller B BMJ Case Rep; 2018 Oct; 2018():. PubMed ID: 30333200 [TBL] [Abstract][Full Text] [Related]
14. Recurrent Apnea in a Neonate Following Intranasal Oxymetazoline. Gopalakrishnan S; Sodhi K Indian Pediatr; 2016 Apr; 53(4):353. PubMed ID: 27156558 [No Abstract] [Full Text] [Related]
15. Anesthetic Efficacy of Intranasal 3% Tetracaine plus 0.05% Oxymetazoline (Kovanaze) in Maxillary Teeth. Capetillo J; Drum M; Reader A; Fowler S; Nusstein J; Beck M J Endod; 2019 Mar; 45(3):257-262. PubMed ID: 30803532 [TBL] [Abstract][Full Text] [Related]
16. Benzalkonium chloride in nasal decongestive sprays has a long-lasting adverse effect on the nasal mucosa of healthy volunteers. Hallén H; Graf P Clin Exp Allergy; 1995 May; 25(5):401-5. PubMed ID: 7553242 [TBL] [Abstract][Full Text] [Related]
17. [Tolerance and effectiveness of oxymetazoline and xylometazoline in treatment of acute rhinitis]. Dorn M; Hofmann W; Knick E HNO; 2003 Oct; 51(10):794-9. PubMed ID: 14523532 [TBL] [Abstract][Full Text] [Related]
18. Oxymetazoline nasal spray three times daily for four weeks in normal subjects is not associated with rebound congestion or tachyphylaxis. Watanabe H; Foo TH; Djazaeri B; Duncombe P; Mackay IS; Durham SR Rhinology; 2003 Sep; 41(3):167-74. PubMed ID: 14579657 [TBL] [Abstract][Full Text] [Related]
19. Thunderclap headache and reversible segmental cerebral vasoconstriction associated with use of oxymetazoline nasal spray. Loewen AH; Hudon ME; Hill MD CMAJ; 2004 Sep; 171(6):593-4. PubMed ID: 15367461 [TBL] [Abstract][Full Text] [Related]
20. Decongestion effect and rebound swelling of the nasal mucosa during 4-week use of oxymetazoline. Graf P; Juto JE ORL J Otorhinolaryngol Relat Spec; 1994; 56(3):157-60. PubMed ID: 7515487 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]